-+ 0.00%
-+ 0.00%
-+ 0.00%

Aegis Capital Reiterates Buy on AEON Biopharma, Maintains $7.2 Price Target

Benzinga·10/08/2025 16:43:21
Listen to the news
Aegis Capital analyst David Bouchey reiterates AEON Biopharma (AMEX:AEON) with a Buy and maintains $7.2 price target.